Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$25.63 - $29.27 $94,933 - $108,416
-3,704 Reduced 12.72%
25,409 $718,000
Q2 2024

Jul 29, 2024

SELL
$26.26 - $29.9 $62,288 - $70,922
-2,372 Reduced 7.53%
29,113 $767,000
Q1 2024

Apr 29, 2024

BUY
$27.46 - $31.33 $222,041 - $253,334
8,086 Added 34.56%
31,485 $956,000
Q4 2023

Feb 07, 2024

SELL
$26.21 - $29.22 $151,493 - $168,891
-5,780 Reduced 19.81%
23,399 $657,000
Q3 2023

Nov 02, 2023

BUY
$26.26 - $31.38 $39,757 - $47,509
1,514 Added 5.47%
29,179 $791,000
Q2 2023

Aug 07, 2023

SELL
$29.6 - $36.56 $280,756 - $346,771
-9,485 Reduced 25.53%
27,665 $850,000
Q1 2023

May 09, 2023

BUY
$32.77 - $39.4 $50,072 - $60,203
1,528 Added 4.29%
37,150 $1.34 Million
Q4 2022

Feb 09, 2023

SELL
$39.17 - $44.04 $196,907 - $221,389
-5,027 Reduced 12.37%
35,622 $1.41 Million
Q3 2022

Nov 09, 2022

SELL
$39.88 - $44.65 $230,626 - $258,210
-5,783 Reduced 12.45%
40,649 $1.63 Million
Q2 2022

Aug 10, 2022

BUY
$37.53 - $44.22 $231,747 - $273,058
6,175 Added 15.34%
46,432 $1.95 Million
Q1 2022

May 09, 2022

BUY
$37.46 - $42.44 $81,213 - $92,009
2,168 Added 5.69%
40,257 $1.57 Million
Q4 2021

Feb 09, 2022

BUY
$35.17 - $42.48 $276,893 - $334,445
7,873 Added 26.06%
38,089 $1.52 Million
Q3 2021

Nov 09, 2021

SELL
$36.14 - $42.24 $54,462 - $63,655
-1,507 Reduced 4.75%
30,216 $1.09 Million
Q2 2021

Aug 10, 2021

BUY
$39.85 - $46.63 $154,458 - $180,737
3,876 Added 13.92%
31,723 $1.3 Million
Q1 2021

May 10, 2021

BUY
$42.34 - $52.82 $603,599 - $753,001
14,256 Added 104.89%
27,847 $1.22 Million
Q4 2020

Feb 08, 2021

SELL
$36.12 - $50.05 $136,678 - $189,389
-3,784 Reduced 21.78%
13,591 $680,000
Q3 2020

Nov 06, 2020

BUY
$38.56 - $48.36 $245,820 - $308,295
6,375 Added 57.95%
17,375 $730,000
Q2 2020

Sep 04, 2020

BUY
$44.5 - $52.11 $489,500 - $573,210
11,000 New
11,000 $534,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.